NCT04648280: Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their CART and Have Dual- or Triple-class Antiretroviral Resistance |
|
|
| Recruiting | 1/2 | 60 | US, RoW | Fostemsavir | PENTA Foundation, ViiV Healthcare, PHPT Foundation, Hospital Universitario 12 de Octubre, Cromsource | HIV Infections with Multi Drug Resistant Virus | 06/25 | 06/28 | | |
| Recruiting | 1/2 | 20 | US | Dolutegravir/Rilpivirine FDC, JULUCA | ViiV Healthcare, Janssen Research & Development, LLC | HIV Infections | 06/26 | 05/28 | | |